The anti-inflammatory role of granulocyte colony-stimulating factor in macrophage- dendritic cell crosstalk after lactobacillus rhamnosus GR-1 exposure

Journal of Leukocyte Biology

Volumn 89, Issue 6, 2011, Pages 907-915

  Martins, Andrew J ^a   Spanton, Sarah ^a   Sheikh, Haroon I ^a   Kim, Sung Ouk ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cytokines; Growth factors; Immunomodulation; Probiotics

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 23; INTERLEUKIN 23P40; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ESCHERICHIA COLI; FEMALE; LACTOBACILLUS RHAMNOSUS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; BLOTTING, WESTERN; CULTURE MEDIA, CONDITIONED; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; INTERLEUKIN-12; INTERLEUKIN-23; LACTOBACILLUS RHAMNOSUS; MACROPHAGES; MALE; MAP KINASE KINASE 4; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

BACTERIA (MICROORGANISMS); LACTOBACILLUS RHAMNOSUS; MUS;

EID: 79957790044     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0810445     Document Type: Article

References (42)

1. Reid, G., Sanders, M. E., Gaskins, H. R., Gibson, G. R, Mercenier, A., Rastall, R, Roberfroid, M., Rowland, I., Cherbut, C, Klaenhammer, T. R (2003) New scientific paradigms for probiotics and prebiotics. J. Clin. Gastroenterol. 37, 105-118.
2. Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food (2002) Guidelines for the Evaluation of Probiotics in Food. ftp.fao.org/es/esn/food/wgreport2pdf
3. Boirivant, M., Strober, W (2007) The mechanism of action of probiotics. Curr. Opin. Gastroenterol. 23, 679-692.
4. Madsen, K. (2006) Probiotics and the immune response. J. Clin. Gastroenterol. 40, 232-234.
5. Cross, M. L. (2002) Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol. Med. Microbiol. 34, 245-253.
6. Braat, H., van den Brande, J., van Tol, E., Hommes, D., Peppelenbosch, M., van Deventer, S. (2004) Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am. J. Clin. Nutr. 80, 1618-1625.
7. Ng, S. C, Hart, A. L., Kamm, M. A, Stagg, A. J., Knight, S. C. (2009) Mechanisms of action of probiotics: recent advances. Inflamm. Bowel Dis. 15, 300-310.
8. Foligne, B., Zoumpopoulou, G., Dewulf, J., Ben Younes, A, Chareyre, F., Sirard, J. C, Pot, B., Grangette, C. (2007) A key role of dendritic cells in probiotic functionality. PLoS ONE 2, e313.
9. Mohamadzadeh, M., Olson, S., Kalina, W. V., Ruthel, G., Demmin, G. L., Warfield, K. L., Bavari, S., Klaenhammer, T. R (2005) Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl. Acad. Sci. USA 102, 2880-2885.
10. Smits, H. H., Engering, A, van der Kleij, D., de Jong, E. C, Schipper, K, van Capel, T. M., Zaat, B. A, Yazdanbakhsh, M., Wierenga, E. A, van Kooyk, Y., Kapsenberg, M. L. (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115, 1260-1267.
11. Drakes, M., Blanchard, T., Czinn, S. (2004) Bacterial probiotic modulation of dendritic cells. Infect. Immun. 72, 3299-3309.
12. Nicola, N. A, Metcalf, D., Matsumoto, M., Johnson, G. R (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J. Biol. Chem. 258, 9017-9023.
13. Roberts, A. W. (2005) G-CSF: a key regulator of neutrophil production, but that's not all! Growth Factors 23, 33-41.
14. Sung, L., Dror, Y (2007) Clinical applications of granulocyte-colony stimulating factor. Front. Biosci. 12, 1988-2002.
15. Kim, S. O., Sheikh, H. I., Ha, S. D., Martins, A, Reid, G. (2006) G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamno-sus -induced suppression of TNF production in macrophages. Cell. Microbiol. 8, 1958-1971.
16. Martins, A J., Colquhoun, P., Reid, G., Kim, S. O. (2009) Reduced expression of basal and probiotic-inducible G-CSF in intestinal mononuclear cells is associated with inflammatory bowel disease. Inflamm. Bowel Dis. 15, 515-525.
17. Dejaco, C, Lichtenberger, C, Miehsler, W., Oberhuber, G., Herbst, F., Vogelsang, H., Gangl, A, Reinisch, W. (2003) An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease. Digestion 68, 63-70.
18. Mannon, P. J., Leon, F., Fuss, I. J., Walter, B. A, Begnami, M., Quezado, M., Yang, Z., Yi, C, Groden, C, Friend, J., Hornung, R L., Brown, M., Gurprasad, S., Kelsall, B., Strober, W. (2009) Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells. Clin. Exp. Immunol. 155, 447-456.
19. Smith, P. D., Ochsenbauer-Jambor, C, Smythies, L. E. (2005) Intestinal macrophages: unique effector cells of the innate immune system. Immunol. Rev. 206, 149-159.
20. Rescigno, M., Lopatin, U., Chieppa, M. (2008) Interactions among dendritic cells, macrophages, and epithelial cells in the gut: implications for immune tolerance. Curr. Opin. Immunol. 20, 669-675.
21. Liu, F., Wu, H. Y, Wesselschmidt, R., Kornaga, T., Link, D. C. (1996) Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5, 491-501.
22. Mukhopadhyay, A, Suttles, J., Stout, R D., Aggarwal, B. B. (2001) Genetic deletion of the tumor necrosis factor receptor p60 or p80 abrogates ligand-mediated activation of nuclear factor-KB and of mitogen-activated protein kinases in macrophages. J. Biol. Chem. 276, 31906-31912.
23. Svanborg, E.C., Hull, R, Falkow, S., Leffler, H. (1983) Target cell specificity of wild-type E. coli and mutants and clones with genetically defined adhesins. Prog. Food Nutr. Sci. 7, 75-89.
24. Rasband, W.S. (1997-2011) Image J. U.S. National Institutes of Health, Bethesda, MD, USA http://imagej.nih.gov/ij/.
25. Snijders, A, Kalinski, P., Hilkens, C. M., Kapsenberg, M. L. (1998) High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10, 1593-1598.
26. Nakahara, T., Moroi, Y, Uchi, H., Furue, M. (2006) Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. J. Dermatol. Sci. 42, 1-11.
27. Agrawal, S., Agrawal, A, Doughty, B., Gerwitz, A, Blenis, J., Van Dyke, T., Pulendran, B. (2003) Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct The responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 171, 4984-4989.
28. Utsugi, M., Dobashi, K, Ono, A, Ishizuka, T., Matsuzaki, S., Hisada, T., Shimizu, Y, Kawata, T., Aoki, H., Kamide, Y, Mori, M. (2009) PI3K p110/3 positively regulates lipopolysaccharide-induced IL-12 production in human macrophages and dendritic cells and JNK1 plays a novel role. J. Immunol. 182, 5225-5231.
29. Shaklee, C. L., Guo, J., Faggioni, R, Fantuzzi, G., Senaldi, G. (2004) Pre-treatment with granulocyte-colony stimulating factor decreases lipopolysaccharide-induced interferon-7 production in mice in association with the production of interleukin-18. Cytokine 25, 119-126.
30. Gorgen, I., Hartung, T, Leist, M., Niehorster, M., Tiegs, G., Uhlig, S., Weitzel, F., Wendel, A (1992) Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-a. J. Immunol 149, 918-924.
31. Mannering, S. I., Zhan, Y, Gilbertson, B., Lieschke, G. J., Cheers, C. (2000) T lymphocytes from granulocyte colony-stimulating factor-/ - mice produce large quantities of interferon-γ in a chronic infection model. Immunology 101, 132-139.
32. Hartung, T., Docke, W. D., Gantner, F., Krieger, G., Sauer, A, Stevens, P., Volk, H. D., Wendel, A. (1995) Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85, 2482-2489.
33. Boneberg, E. M., Hareng, L., Gantner, F., Wendel, A, Hartung, T. (2000) Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-γ. Blood 95, 270-276.
34. Arpinati, M., Green, C. L., Heimfeld, S., Heuser, J. E., Anasetti, C. (2000) Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95, 2484-2490.
35. Hill, G R., Olver, S. D., Kuns, R D., Varelias, A, Raffelt, N C., Don, A L., Mar-key, K A., Wilson, Y A., Smyth, M. J., Iwakura, Y, Tocker, J., Clouston, A D., Macdonald, K P. (2010) Stem cell mobilization with G-CSF induces type-17 differentiation and promotes scleroderma. Blood 116, 819-828.
36. Sun, L-X., Ren, H-Y, Shi, Y-J., Wang, L-H., Qiu, Z-X. (2009) Recombinant human granulocyte colony-stimulating factor significantly decreases the expression of CXCR3 and CCR6 on T cells and preferentially induces T helper cells to a T helper 17 phenotype in peripheral blood harvests. Biol. Blood Marrow Transplant. 15, 835-843.
37. Toh, H. C, Sun, L., Soe, Y, Wu, Y, Phoon, Y P., Chia, W. K, Wu, J., Wong, K Y, Tan, P. (2009) G-CSF induces a potentially tolerant gene and immuno-phenotype profile in T cells in vivo. Clin. Immunol. 132, 83-92.
38. Kudo, T., Matsumoto, T., Nakamichi, I., Yada, S., Esaki, M., Jo, Y, Ohji, Y, Yao, T., Iida, M. (2008) Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis. Scand. J. Gastroenterol. 43, 689-697.
39. Egi, H., Hayamizu, K, Yoshimitsu, M., Shimamoto, F., Oishi, K, Ohmori, I., Okajima, M., Asahara, T. (2003) Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor. Cytokine 23, 23-30.
40. Hommes, D. W., Meenan, J., Dijkhuizen, S., Ten Kate, F. J., Tytgat, G. N., Van Deventer, S.J. (1996) Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis. Clin. Exp. Immunol. 106, 529-533.
41. Korzenik, J. R, Dieckgraefe, B. K (2005) An open-labeled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease. Aliment. Pharmacol Ther. 21, 391-400.
42. Bharadwaj, U., Li, M., Zhang, R, Chen, C, Yao, Q. (2007) Elevated inter-leukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res. 67, 5479-5488.